Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation - Weitz, J I; Connolly, S J; Patel, I (Thromb Haemost, 2010)
, et al.